L. Baitinger

Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial.

M. Kavuru, C. Laforce, B. Prillaman, 2000, The Journal of allergy and clinical immunology.

Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.

P. Dorinsky, J. Murray, R. Rosenthal, 2004, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Efficacy and Safety of Fluticasone Propionate/Salmeterol HFA 134A MDI in Patients with Mild‐to‐Moderate Persistent Asthma

P. Dorinsky, D. Peden, C. Scott, 2004, The Journal of asthma : official journal of the Association for the Care of Asthma.

Efficacy and safety of fluticasone propionate 44 microg/salmeterol 21 microg administered in a hydrofluoroalkane metered-dose inhaler as an initial asthma maintenance treatment.

P. Dorinsky, H. Nelson, C. Scott, 2003, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Combined salmeterol 50 microg and fluticasone propionate 250 microg in the diskus device for the treatment of asthma.

W. Lumry, J. Given, M. White, 2000, American journal of respiratory and critical care medicine.

Efficacy and safety of fluticasone propionate 44 microg/salmeterol 21 microg administered in a hydrofluoroalkane metered-dose inhaler as an initial asthma maintenance treatment.

P. Dorinsky, H. Nelson, C. Scott, 2003, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Variability in asthma severity in pediatric subjects with asthma previously receiving short-acting beta2-agonists.

P. Dorinsky, C. Sorkness, B. Chipps, 2006, The Journal of pediatrics.

Combined Salmeterol 50 μ g and Fluticasone Propionate 250 μ g in the Diskus Device for the Treatment of Asthma

W. Lumry, G. Shapiro, J. Given, 2000 .

Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.

L. Edwards, P. Dorinsky, E. Bleecker, 2006, The Journal of allergy and clinical immunology.